Trial NCT01653418

View at ClinicalTrials.gov 
Org. Study IDs: 201208046

Last trial update was posted on 2014-10-15

MeSH Interventions

Bortezomib Carmustine Cytarabine Etoposide Melphalan

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

Due to the high rate of morbidity and mortality

Limitations And Caveats

2 early deaths caused a concern for safety and resulted in suspension of enrollment in May 2013. After a review of the data, the investigators determined that this regimen had unexpected toxicity & the trial was closed to enrollment in June 2013.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID